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Pilot Survey for a Nation-wide Patterns of Care Study
on How Radiation Oncologists Treat Gastric Cancer
April Pearson
Lehigh Valley Health Network, Allentown, PA

Background

Results

Gastric cancer is the 4th most common cancer,
and 2nd leading cause of cancer-related deaths
worldwide. In most cases, surgical resection is
the mainstay of treatment, however many times
the tumor is found late-stage and there are
questions as to how to treat these patients. First,
the type of surgery performed, and how extensive
of a lymph node dissection should be done is
highly contested. Secondly, what is the role of
chemotherapy and radiotherapy treatment? In the
studies that have been conducted so far, it is clear
that adjuvant therapy is significantly beneficial.
However, there is no internationally accepted
standard of care established for this adjuvant
therapy. The treatment of gastric cancer is not
thoroughly studied, therefore radiation oncologists
and medical oncologists alike utilize a great variety
of treatment options. More studies are needed
to evaluate the role of radiotherapy, as well as
what is currently being practiced by radiation
oncologists. The purpose of this study was to
pilot a survey at LVHN with the final intention of
distributing this survey nationally to determine
what strategies are being utilized to treat gastric
cancer by radiation oncologists throughout the
United States.

The results of our initial pilot survey showed agreement on some items between the 6 radiation oncologists
at LVHN, and disagreement on others. All 6 radiation oncologists discuss about 30-49% of their gastric
cancer patients at tumor board. Everyone agreed that a D2 nodal dissection is performed during a
gastrectomy at LVHN, and everyone utilizes perioperative therapy when treating a T2 or higher, node
negative gastric cancer after D2 dissection. Furthermore there was concurrence between all 6 radiation
oncologists with giving a dose between 50-55Gy, using respiratory gating or 4DCT for treatment planning,
and always using image guided radiotherapy during treatment of their gastric cancer patients. There
were also some points of contention. One radiation oncologist stated they recommended postoperative
chemotherapy alone for their patients with T2 or higher, node negative gastric cancer after D2 dissection,
while the other 5 physicians recommend postoperative chemotherapy plus radiation. Four surveyors states
they took into consideration the histologic subtype into consideration of their therapy recommendations,
while the other 2 radiation oncologists did not. For radiotherapy delivery, 2 radiation oncologists use
intensity modulated radiation therapy (IMRT) alone, where as the other 4 surveyors used IMRT with cone
beam CT image guidance and simultaneous integrated boost. Lastly, there are two different chemotherapy
regimens being used at LVHN – the first being ECF based off the MAGIC trial and the second is 5FU-based +
Oxaliplatin based off the CLASSIC trial.

Problem Statement
How is gastric cancer being treated by radiation
oncologists in the United States?

Methodology
A 17 question survey was drafted with questions
asking radiation oncologists how they treat their
patients with gastric cancer. 11 questions were
specific to treatment while the other 6 questions
asked the surveyor about their demographics
and the percentage of patients they treat with
gastric cancer on a yearly basis. The survey was
piloted amongst 6 radiation oncologists at LVHN to
ensure the questions are clearly understood with
no room for misinterpretation. This survey is in
the process of being approved by the Department
of Medicine Research Review Committee. After
full IRB approval the survey will be distributed to
300 radiation oncologists through the ASTRO USA
database.

Conclusions
With just the initial pilot survey we see that in the same institution, there are some areas which radiation
oncologists practice similarly, and there are other areas where there are differences in how radiation
oncologists treat their patients with gastric cancer. It is expected that this trend will be seen in the nationwide survey.
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